Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.

Also called NCT01379677

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 135 participants (enrolled count) (from the registry)
Sponsor
Advanced Accelerator Applications (from the registry)
Registry
  • NCT NCT01379677
  • EudraCT 2009-016645-25
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01379677. Non-randomized; no masking; primary purpose diagnostic. Start 2011-02 (registry gives no type); primary completion 2013-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison
Intervention (Drug)
Rubidium-82
Intervention (Drug)
Sestamibi. reconstitution with sodium pertechnetate (99mTc)
Lead sponsor
Advanced Accelerator Applications (class: industry)

Record details

Record id
cardio:ct-nct01379677
Content hash
c44d8a97721feda5e3f1bc8e76f95b8ed99ff8b347b9910c473c36b7fd565f5c